![](/img/cover-not-exists.png)
P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated with Immunotherapy and Ramucirumab Plus Docetaxel.
Fughhi, I., Bonomi, P., Fidler, M.J., Basu, S., Borgia, J., Batus, M.Volume:
13
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.1088
Date:
October, 2018
File:
PDF, 217 KB
2018